Skip to content

MIMEDX GROUP, INC.

MDXG

CIK 0001376339 · Surgical & Medical Instruments & Apparatus · Nasdaq

  • Alynx, Co. (until 2008-04-02)
← back to feed
Revenue (TTM)
$359.53M
+20.0% YoY Q1 Apr 2026
Net Income (TTM)
$22.53M
+14.5% YoY Q1 Apr 2026
EPS Diluted (TTM)
$0.15
+14.3% YoY Q1 Apr 2026
Gross Margin
80.2%
Q1 Apr 2026
Operating Margin
7.4%
Q1 Apr 2026
Net Margin
6.3%
Q1 Apr 2026
Free Cash Flow (TTM)
$7.12M
Q1 Apr 2026
Cash
$159.77M
Q1 Apr 2026
Total Debt
$17.59M
Q1 Apr 2026
Shares Outstanding
148.95M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings